{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:43:43Z","timestamp":1772631823733,"version":"3.50.1"},"reference-count":43,"publisher":"IOP Publishing","issue":"9","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"}],"funder":[{"name":"Cancer Research Program of National Cancer Center","award":["NCC201917B02"],"award-info":[{"award-number":["NCC201917B02"]}]},{"DOI":"10.13039\/501100002948","name":"Hubei University of Technology","doi-asserted-by":"crossref","award":["XJ2021003301"],"award-info":[{"award-number":["XJ2021003301"]}],"id":[{"id":"10.13039\/501100002948","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the projects of Knowledge Innovation Program of Wuhan-Basi Research","award":["2022020801010511"],"award-info":[{"award-number":["2022020801010511"]}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Nanotechnology"],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Triple-negative breast cancer (TNBC) presents significant therapeutic challenges due to its aggressive nature and lack of molecular targets. To address this challenge, we developed a pH\/thermo-responsive nanoplatform based on epigallocatechin-3-gallate (EGCG) modified lipid-coated polydopamine (TEDP), capable of loading doxorubicin (DOX). EGCG, a bioactive polyphenol with high affinity for laminin receptors overexpressed in cancer cells, served both as a targeting ligand and immune microenvironment remodeling regent, enabling selective uptake and remodeling immunosuppression cells. Thermosensitive EGCG modified DOX loaded PDA (TEDP) nanoparticles exhibited spherical morphology (\u223c140 nm), good colloidal stability, and efficient photothermal conversion under near-infrared irradiation. Under a trigger temperature and pH 6.0, TEDP exhibited pH\/temperature-triggered drug release, achieving 70% precise drug release within 4 h, thereby enabling spatiotemporally controlled drug release. Both\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    experiments demonstrated that TEDP nanoparticles could significantly enhance targeting, ensuring precise drug release at the tumor site while minimizing off-target toxicity of DOX. In a TNBC tumor model, the tumor suppression efficacy of TEDP treatment exceeded that of chemotherapy or photothermal therapy (PTT) monotherapy by 3.2-fold and 1.7-fold, respectively. The findings highlighted that TEDP nanoparticles generated synergistic enhancement effects through chemotherapy, PTT and anti-tumor immune responses activating. The multimodal nanoplatform would hold great promise in TNBC therapy, offering a strategy to overcome the limitations of conventional monotherapies.\n                  <\/jats:p>","DOI":"10.1088\/1361-6528\/ae4735","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:47:37Z","timestamp":1771426057000},"page":"095101","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Microenvironment-responsive EGCG-functionalized nanoplatform for synergistic photothermal-chemotherapy against triple-negative breast cancer"],"prefix":"10.1088","volume":"37","author":[{"given":"Qiaoxin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3991-7983","authenticated-orcid":true,"given":"Zilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengdie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-8857","authenticated-orcid":true,"given":"Hongda","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"nanoae4735bib1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmatsci.2023.101070","type":"journal-article","article-title":"Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer","volume":"134","author":"Kong","year":"2023","journal-title":"Pro. Mater. Sci."},{"key":"nanoae4735bib2","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jama.2024.26886","type":"journal-article","article-title":"Adjuvant atezolizumab for early triple-negative breast cancer: the ALEXANDRA\/IMpassion030 randomized clinical trial","volume":"333","author":"Ignatiadis","year":"2025","journal-title":"JAMA"},{"key":"nanoae4735bib3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071674","type":"journal-article","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"nanoae4735bib4","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202307756","type":"journal-article","article-title":"Synergistic approach to combat triple\u2010negative breast cancer: B7\u2010H4 checkpoint\u2010based photodynamic nanodrug coupled with neutrophil extracellular trap regulation","volume":"33","author":"Jiang","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"nanoae4735bib5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12964-024-01952-9","type":"journal-article","article-title":"The role of circRNAs in resistance to doxorubicin","volume":"22","author":"Sanati","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"nanoae4735bib6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12964-023-01077-5","type":"journal-article","article-title":"Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy","volume":"21","author":"Shi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"nanoae4735bib7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jconrel.2024.03.046","type":"journal-article","article-title":"Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin","volume":"369","author":"Kim","year":"2024","journal-title":"J. Control. Release"},{"key":"nanoae4735bib8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","type":"journal-article","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"nanoae4735bib9","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","type":"journal-article","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"key":"nanoae4735bib10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3390\/nano12060922","type":"journal-article","article-title":"Nanoparticle-mediated photothermal therapy limitation in clinical applications regarding pain management","volume":"12","author":"Salimi","year":"2022","journal-title":"Nanomaterials"},{"key":"nanoae4735bib11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.xphs.2024.11.004","type":"journal-article","article-title":"Ultrasound\/magnetic resonance bimodal imaging-guided CD20-targeted multifunctional nanoplatform for photothermal\/chemo synergistic therapy of B-cell lymphoma","volume":"114","author":"Wang","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"nanoae4735bib12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124488","type":"journal-article","article-title":"Redox and pH dual sensitive carboxymethyl chitosan functionalized polydopamine nanoparticles loaded with doxorubicin for tumor chemo-photothermal therapy","volume":"240","author":"Zhu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"nanoae4735bib13","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.xphs.2024.02.005","type":"journal-article","article-title":"Improving chemotherapy effectiveness: utilizing CuS nanoparticles coated with AS1411 aptamer and chitosan for targeted delivery of doxorubicin to cancerous cells","volume":"113","author":"Imanimoghadam","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"nanoae4735bib14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12951-022-01698-x","type":"journal-article","article-title":"Melanin-like nanoparticles: advances in surface modification and tumour photothermal therapy","volume":"20","author":"Tian","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"nanoae4735bib15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125191","type":"journal-article","article-title":"Design and evaluation of a multi-responsive dual-modality bone-targeted drug delivery vehicle for the treatment of osteosarcoma","volume":"671","author":"Huang","year":"2025","journal-title":"Int. J. Pharm."},{"key":"nanoae4735bib16","doi-asserted-by":"publisher","DOI":"10.1002\/smsc.202300242","type":"journal-article","article-title":"Suppressing the hypoxia\u2010adenosinergic axis by a tailored nanoreactor for enhanced photothermal immunotherapy","volume":"4","author":"Gu","year":"2024","journal-title":"Small Sci."},{"key":"nanoae4735bib17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12951-023-02072-1","type":"journal-article","article-title":"A versatile PDA(DOX) nanoplatform for chemo-photothermal synergistic therapy against breast cancer and attenuated doxorubicin-induced cardiotoxicity","volume":"21","author":"Geng","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"nanoae4735bib18","doi-asserted-by":"publisher","first-page":"14866","DOI":"10.1021\/acsami.9b22979","type":"journal-article","article-title":"Amplified photoacoustic signal and enhanced photothermal conversion of polydopamine-coated gold nanobipyramids for phototheranostics and synergistic chemotherapy","volume":"12","author":"Liu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"nanoae4735bib19","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/ad22a5","type":"journal-article","article-title":"Polydopamine nanoplatform with near infrared light and pH dual stimuli-responsive for chemo-photothermal cancer therapy","volume":"35","author":"Tan","year":"2024","journal-title":"Nanotechnology"},{"key":"nanoae4735bib20","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.132135","type":"journal-article","article-title":"Epigallocatechin 3-gallate: from green tea to cancer therapeutics","volume":"379","author":"Alam","year":"2022","journal-title":"Food Chem."},{"key":"nanoae4735bib21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1021\/acsabm.1c01149","type":"journal-article","article-title":"Size dependency of selective cellular uptake of epigallocatechin gallate-modified gold nanoparticles for effective radiosensitization","volume":"5","author":"Gan","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"nanoae4735bib22","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/acaca3","type":"journal-article","article-title":"The applications of epigallocatechin gallate (EGCG)-nanogold conjugate in cancer therapy","volume":"34","author":"Karimi-Shahri","year":"2023","journal-title":"Nanotechnology"},{"key":"nanoae4735bib23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijpharm.2018.02.041","type":"journal-article","article-title":"Dual-effect liposomes with increased antitumor effects against 67-kDa laminin receptor-overexpressing tumor cells","volume":"541","author":"Sugiyama","year":"2018","journal-title":"Int. J. Pharm."},{"key":"nanoae4735bib24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.108536","type":"journal-article","article-title":"Tumor-targeted self-assembled micelles reducing PD-L1 expression combined with ICIs to enhance chemo-immunotherapy of TNBC","volume":"35","author":"Zhu","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"nanoae4735bib25","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2024.107426","type":"journal-article","article-title":"Bothrops atrox snake venom decreased MHC-II and CD86 expression in bone marrow-derived dendritic cells","volume":"260","author":"da Silva","year":"2024","journal-title":"Acta Trop."},{"key":"nanoae4735bib26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.actbio.2024.02.003","type":"journal-article","article-title":"A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy","volume":"177","author":"Wang","year":"2024","journal-title":"Acta Biomater."},{"key":"nanoae4735bib27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104509","type":"journal-article","article-title":"Cisplatin-loaded thermoresponsive liposomes for enhanced anticancer efficacy","volume":"84","author":"Shah","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"nanoae4735bib28","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.2147\/IJN.S378217","type":"journal-article","article-title":"PDA-based drug delivery nanosystems: a potential approach for glioma treatment","volume":"17","author":"Wu","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"nanoae4735bib29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jconrel.2020.04.029","type":"journal-article","article-title":"Smart gold nanocages for mild heat-triggered drug release and breaking chemoresistance","volume":"323","author":"He","year":"2020","journal-title":"J. Control. Release"},{"key":"nanoae4735bib30","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/pharmaceutics14081523","type":"journal-article","article-title":"laminin receptor-mediated nanoparticle uptake by tumor cells: interplay of epigallocatechin gallate and magnetic force at nano\u2013bio interface","volume":"14","author":"Hsu","year":"2022","journal-title":"Pharmaceutics"},{"key":"nanoae4735bib31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.17305\/bb.2024.10323","type":"journal-article","article-title":"Reconsideration of the laminin receptor 67LR in colorectal cancer cells","volume":"24","author":"Cloutier","year":"2024","journal-title":"Biomol. Biomed."},{"key":"nanoae4735bib32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037942","type":"journal-article","article-title":"Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor","volume":"7","author":"Fujimura","year":"2012","journal-title":"PLoS One"},{"key":"nanoae4735bib33","doi-asserted-by":"publisher","first-page":"7133","DOI":"10.2147\/IJN.S436253","type":"journal-article","article-title":"A novel pH-responsive iron oxide core-shell magnetic mesoporous silica nanoparticle (M-MSN) system encapsulating doxorubicin (DOX) and glucose oxidase (Gox) for pancreatic cancer treatment","volume":"18","author":"Qi","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"nanoae4735bib34","doi-asserted-by":"publisher","first-page":"59814","DOI":"10.1021\/acsami.4c11594","type":"journal-article","article-title":"Polydopamine nanoformulations Induced ICD and M1 phenotype macrophage polarization for enhanced TNBC synergistic photothermal immunotherapy","volume":"16","author":"Geng","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"nanoae4735bib35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138434","type":"journal-article","article-title":"Chitosan-derived drug free \u201cartificial beacon\u201d simulating immunogenetic cell death cascade effector to initiate immune response for cancer therapy","volume":"287","author":"Lou","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"nanoae4735bib36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122369","type":"journal-article","article-title":"Biomimetic Prussian blue nanocomplexes for chemo-photothermal treatment of triple-negative breast cancer by enhancing ICD","volume":"303","author":"Long","year":"2023","journal-title":"Biomaterials"},{"key":"nanoae4735bib37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","type":"journal-article","article-title":"Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"nanoae4735bib38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2021.04.013","type":"journal-article","article-title":"Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy","volume":"334","author":"Yang","year":"2021","journal-title":"J. Control. Release"},{"key":"nanoae4735bib39","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.3390\/ijms24044002","type":"journal-article","article-title":"Crosstalk of inflammatory cytokines within the breast tumor microenvironment","volume":"24","author":"Habanjar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"nanoae4735bib40","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41584-021-00694-z","type":"journal-article","article-title":"Targeting interferon-gamma in hyperinflammation: opportunities and challenges","volume":"17","author":"De Benedetti","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"nanoae4735bib41","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cell.2017.11.037","type":"journal-article","article-title":"Natural killer cells control tumor growth by sensing a growth factor","volume":"172","author":"Barrow","year":"2018","journal-title":"Cell"},{"key":"nanoae4735bib42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/tcr.202000170","type":"journal-article","article-title":"Polydopamine\u2010based nanoparticles for photothermal therapy\/chemotherapy and their synergistic therapy with autophagy inhibitor to promote antitumor treatment","volume":"21","author":"Lu","year":"2021","journal-title":"Chem. Rec."},{"key":"nanoae4735bib43","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300929","type":"journal-article","article-title":"A dual heat shock protein down\u2010regulation strategy using PDA\/Cu\/ICG\/R controlled by nir \u201cswitch\u201d enhances mild\u2010photothermal therapy effect","volume":"12","author":"Ding","year":"2023","journal-title":"Adv. Healthc. Mater."}],"container-title":["Nanotechnology"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:36:15Z","timestamp":1772606175000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ae4735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,3,4]]},"published-print":{"date-parts":[[2026,3,6]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6528\/ae4735","relation":{},"ISSN":["0957-4484","1361-6528"],"issn-type":[{"value":"0957-4484","type":"print"},{"value":"1361-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"Microenvironment-responsive EGCG-functionalized nanoplatform for synergistic photothermal-chemotherapy against triple-negative breast cancer","name":"article_title","label":"Article Title"},{"value":"Nanotechnology","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2026 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2025-12-09","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-02-17","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-03-04","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}